226 related articles for article (PubMed ID: 20054639)
1. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies.
Gu D; Wang M; Zhang Z; Chen J
Breast Cancer Res Treat; 2010 Jul; 122(2):527-31. PubMed ID: 20054639
[TBL] [Abstract][Full Text] [Related]
2. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
[TBL] [Abstract][Full Text] [Related]
3. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
Li H; Hao X; Zhang W; Wei Q; Chen K
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD
Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842
[TBL] [Abstract][Full Text] [Related]
5. The functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk: evidence from 1180 cases and 2444 controls.
Ni M; Qiu J; He W; Wang X
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):683-7. PubMed ID: 22343785
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
[TBL] [Abstract][Full Text] [Related]
7. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
8. Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan.
Chang CH; Hsiao CF; Chang GC; Tsai YH; Chen YM; Huang MS; Su WC; Hsieh WS; Yang PC; Chen CJ; Hsiung CA
Am J Epidemiol; 2009 Sep; 170(6):695-702. PubMed ID: 19671832
[TBL] [Abstract][Full Text] [Related]
9. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type.
Okasaka T; Matsuo K; Suzuki T; Ito H; Hosono S; Kawase T; Watanabe M; Yatabe Y; Hida T; Mitsudomi T; Tanaka H; Yokoi K; Tajima K
J Hum Genet; 2009 Dec; 54(12):739-45. PubMed ID: 19881468
[TBL] [Abstract][Full Text] [Related]
10. hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population.
Li Q; Huang L; Rong L; Xue Y; Lu Q; Rui Y; Li J; Tong N; Wang M; Zhang Z; Fang Y
Cancer Sci; 2011 Jun; 102(6):1123-7. PubMed ID: 21401806
[TBL] [Abstract][Full Text] [Related]
11. The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects.
Yao L; Cao LH; Qiu LX; Yu L
Breast Cancer Res Treat; 2010 Sep; 123(2):577-80. PubMed ID: 20151320
[TBL] [Abstract][Full Text] [Related]
12. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.
Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z
Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210
[TBL] [Abstract][Full Text] [Related]
13. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.
Sugimura H; Kohno T; Wakai K; Nagura K; Genka K; Igarashi H; Morris BJ; Baba S; Ohno Y; Gao C; Li Z; Wang J; Takezaki T; Tajima K; Varga T; Sawaguchi T; Lum JK; Martinson JJ; Tsugane S; Iwamasa T; Shinmura K; Yokota J
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):669-74. PubMed ID: 10744126
[TBL] [Abstract][Full Text] [Related]
14. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
16. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
Gu D; Zhuang L; Huang H; Cao P; Wang D; Tang J; Chen J
Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies.
Guo CL; Han FF; Wang HY; Wang L
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1443-8. PubMed ID: 22526153
[TBL] [Abstract][Full Text] [Related]
18. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.
Wei B; Zhou Y; Xu Z; Xi B; Cheng H; Ruan J; Zhu M; Hu Q; Wang Q; Wang Z; Yan Z; Jin K; Zhou D; Xuan F; Huang X; Shao J; Lu P
PLoS One; 2011; 6(11):e27545. PubMed ID: 22114677
[TBL] [Abstract][Full Text] [Related]
19. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():108. PubMed ID: 24893568
[TBL] [Abstract][Full Text] [Related]
20. Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.
Romanowicz-Makowska H; Smolarz B; Makowski M; Połać I; Pertyński T
Pol J Pathol; 2008; 59(4):201-4. PubMed ID: 19391486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
